• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Next generation medical therapy for Cushing's Syndrome-can we measure a benefit?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Trainer, Peter J
    Affiliation
    The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom
    Issue Date
    2014-04
    
    Metadata
    Show full item record
    Citation
    Next generation medical therapy for Cushing's Syndrome-can we measure a benefit? 2014, 99 (4):1157-60 J Clin Endocrinol Metab
    Journal
    The Journal of Clinical Endocrinology and Metabolism
    URI
    http://hdl.handle.net/10541/315944
    DOI
    10.1210/jc.2014-1054
    PubMed ID
    24702012
    Type
    Article
    Language
    en
    ISSN
    1945-7197
    ae974a485f413a2113503eed53cd6c53
    10.1210/jc.2014-1054
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Pharmacotherapy: a new option for Cushing disease?
    • Authors: Heath V
    • Issue date: 2014 Mar
    • LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study.
    • Authors: Bertagna X, Pivonello R, Fleseriu M, Zhang Y, Robinson P, Taylor A, Watson CE, Maldonado M, Hamrahian AH, Boscaro M, Biller BM
    • Issue date: 2014 Apr
    • Osilodrostat (Isturisa) for Cushing's disease.
    • Issue date: 2021 Feb 8
    • Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing's disease.
    • Authors: Fontaine-Sylvestre C, Létourneau-Guillon L, Moumdjian RA, Berthelet F, Lacroix A
    • Issue date: 2021 Apr
    • Efficacy and tolerance of osilodrostat in patients with Cushing's syndrome due to adrenocortical carcinomas.
    • Authors: Tabarin A, Haissaguerre M, Lassole H, Jannin A, Paepegaey AC, Chabre O, Young J
    • Issue date: 2022 Jan 6
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.